ANAPTYSBIO (ANAB) reports ownership of 100 First Tracks Biotherapeutics shares
Rhea-AI Filing Summary
ANAPTYSBIO, INC, identified as a ten percent owner of First Tracks Biotherapeutics, Inc., filed an initial ownership report. In connection with the spin-off of First Tracks under a Separation and Distribution Agreement dated April 1, 2026, ANAPTYSBIO owns all 100 outstanding shares of First Tracks common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
ANAPTYSBIO, INC
Role
10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 100 shares (Direct)
Footnotes (1)
- F1. In connection with the spin-off of First Tracks Biotherapeutics, Inc. ("First Tracks") by the Reporting Person, as defined in the Separation and Distribution Agreement, dated April 1, 2026, between the Reporting Person and First Tracks, a wholly owned subsidiary of the Reporting Person, the Reporting Person on April 1, 2026 owns all 100 outstanding shares of common stock of First Tracks.
Key Figures
Form type: Form 3
Shares owned: 100 shares
Spin-off date: April 1, 2026
3 metrics
Form type
Form 3
Initial statement of beneficial ownership
Shares owned
100 shares
Outstanding shares of First Tracks common stock owned by ANAPTYSBIO
Spin-off date
April 1, 2026
Date of Separation and Distribution Agreement and spin-off
Key Terms
spin-off, Separation and Distribution Agreement, outstanding shares of common stock, ten percent owner
4 terms
spin-off financial
"In connection with the spin-off of First Tracks Biotherapeutics, Inc."
A spin-off happens when a company creates a new, independent business by separating part of itself, like splitting off a division into its own company. This often happens so the new company can focus better on its own goals or attract different investors. It matters because it can lead to more growth opportunities and clearer focus for both companies.
Separation and Distribution Agreement financial
"as defined in the Separation and Distribution Agreement, dated April 1, 2026"
A separation and distribution agreement is the legal plan that sets out how a company splits into two parts and how ownership of the new business is handed to shareholders. Think of it like a divorce settlement and moving checklist combined — it allocates assets, debts, tax responsibilities and short‑term services so both businesses can operate on their own. Investors care because the terms determine who bears future risks, costs and potential value when the split completes.
ten percent owner regulatory
"Reporting Person is marked as a ten percent owner"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What ownership in First Tracks Biotherapeutics does ANAPTYSBIO, INC report?
ANAPTYSBIO, INC reports ownership of all 100 outstanding shares of common stock of First Tracks Biotherapeutics, Inc. This reflects its entire equity position in First Tracks as described in the filing’s ownership table and related footnote.
What transaction is associated with ANAPTYSBIO’s First Tracks holdings on April 1, 2026?
The filing ties ANAPTYSBIO’s First Tracks holdings to a spin-off effective April 1, 2026. Under a Separation and Distribution Agreement dated that day, ANAPTYSBIO owns all 100 outstanding shares of First Tracks common stock.
Why does ANAPTYSBIO, INC qualify as a ten percent owner in this filing?
ANAPTYSBIO, INC is identified as a ten percent owner because it holds all 100 outstanding shares of First Tracks Biotherapeutics common stock. This complete ownership stake meets the threshold for ten percent owner status in the report.
What agreement governs the spin-off of First Tracks Biotherapeutics from ANAPTYSBIO?
The relationship is governed by a Separation and Distribution Agreement dated April 1, 2026 between ANAPTYSBIO, INC and First Tracks Biotherapeutics, Inc. The agreement is referenced in the footnote describing the spin-off and resulting share ownership.